Biosensors: the new wave in cancer diagnosis
Open Access
- 1 December 2010
- journal article
- review article
- Published by Taylor & Francis Ltd in Nanotechnology, Science and Applications
- Vol. 4, 1-10
- https://doi.org/10.2147/nsa.s13465
Abstract
The earlier cancer can be detected, the better the chance of a cure. Currently, many cancers are diagnosed only after they have metastasized throughout the body. Effective, accurate methods of cancer detection and clinical diagnosis are urgently needed. Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents. This review will briefly summarize the current obstacles to early detection of cancer and the expanding use of biosensors as a diagnostic tool, as well as some future applications of biosensor technology.Keywords
This publication has 53 references indexed in Scilit:
- Biosensors for cancer markers diagnosisSeminars in Cell & Developmental Biology, 2009
- Current issues in ER and HER2 testing by IHC in breast cancerLaboratory Investigation, 2008
- Applications of Nanobiotechnology in Clinical DiagnosticsClinical Chemistry, 2007
- Development of biosensors for cancer clinical testingBiosensors and Bioelectronics, 2006
- Epigenetic change in pituitary tumorigenesis.Endocrine-Related Cancer, 2003
- Humoral immune responses of cancer patients against “Cancer-Testis” antigen NY-ESO-1: Correlation with clinical eventsInternational Journal of Cancer, 1999
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience.1997
- Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors.1997
- Frequency and parental origin of hypermethylated RB1 alleles in retinoblastomaHuman Genetics, 1994